Carfilzomib is administered as an intravenous infusion. The dosage and schedule depend on the specific treatment regimen and the patient's response to therapy. Typically, it is given over a period of two consecutive days each week for three weeks, followed by a week of rest. Treatment cycles may continue as long as the patient benefits from the therapy.
